Oscine Therapeutics

Oscine Therapeutics is a company developing a cell therapy platform for the treatment of CNS diseases. It provides a platform that generates bipotential astrocyte-oligodendrocyte glial progenitor cells and replaces lost, damaged or dysfunctional glial cells in patients with degenerative diseases and diseases of the white matter.